An independent reanalysis of 11 randomized clinical trials shows that 
oseltamivir treatment reduces the risk of lower respiratory tract complications 
requiring antibiotic treatment by 28% overall (95% confidence interval [CI], 
11%-42%) and by 37% among patients with confirmed influenza infections (95% CI, 
18%-52%).